Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients
- 31 May 1996
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 100 (5) , 496-501
- https://doi.org/10.1016/s0002-9343(97)89503-4
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Visceral leishmaniasis in HIV-1 -infected individualsAIDS, 1992
- Prevalence of Leishmania infection among AIDS patientsThe Lancet, 1992
- Visceral leishmaniasisAIDS, 1991
- Visceral Leishmaniasis in HIV Infection and AIDS: Clinical Features and Response to TherapyQJM: An International Journal of Medicine, 1990
- Visceral leishmaniasis in patients infected with human immunodeficiency virusJournal of Infection, 1990
- Visceral leishmaniasis in immunocompromised hostsThe American Journal of Medicine, 1987
- LEISHMANIA DONOVANI: AN OPPORTUNISTIC MICROBE ASSOCIATED WITH PROGRESSIVE DISEASE IN THREE IMMUNOCOMPROMISED PATIENTSThe Lancet, 1986
- The Immunobiology of LeishmaniasisClinical Infectious Diseases, 1983
- Evaluation of allopurinol in the treatment of kala-azar occurring in North Bihar, IndiaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1983
- Antileishmanial effect of allopurinol and allopurinol ribonucleoside on intracellular forms of Leishmania donovaniBiochemical Pharmacology, 1980